Kennedy Capital Management, Inc. Bio Line Rx Ltd. Transaction History
Kennedy Capital Management, Inc.
- $4.23 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding BLRX
# of Institutions
37Shares Held
2.98MCall Options Held
75.1KPut Options Held
5.1K-
Highbridge Capital Management LLC New York, NY1.01MShares$3.82 Million0.05% of portfolio
-
Cvi Holdings, LLC Wilmington, DE816KShares$3.08 Million4.05% of portfolio
-
Values First Advisors, Inc.166KShares$629,1770.02% of portfolio
-
Pvg Asset Management Corp Golden, CO157KShares$594,2720.37% of portfolio
-
Atria Wealth Solutions, Inc. New York, NY94.1KShares$355,8220.0% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $233M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...